Japer Therapeutics, Inc. Warrants (NASDAQ: JSPRW) last traded at $0.000200, down 84.62% on the session. The quote above updates while this page is open; the figures below are drawn from Japer Therapeutics, Inc. Warrants’s own filings and are restated only when a new one is published.
Japer Therapeutics, Inc. Warrants trades on NASDAQ under the ticker JSPRW. Its market capitalisation is $6,654.912.
Valuation measures for Japer Therapeutics, Inc. Warrants, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.7K |
|---|---|
| Enterprise value | $3.08M |
| Price / book | 0.00 |
Trailing-twelve-month figures tagged in Japer Therapeutics, Inc. Warrants's XBRL filings with the SEC.
| Net income (TTM) | -$31.77M |
|---|---|
| EPS (TTM) |
| -$0.940 |
| Return on equity | -2248.48% |
|---|
| Cash | $7.31M |
|---|
Range and volume for JSPRW over the past 52 weeks.
| 52-week high | $0.00390 |
|---|---|
| 52-week low | $0.000100 |
| Volume | 863.1K |
| Average volume | 863.1K |
| Previous close | $0.00130 |
Invest a chosen dollar amount in Japer Therapeutics, Inc. Warrants with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell JSPRW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.